Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma
NCT07131644Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in kaposiform hemangioendothelioma (KHE), sponsored by West China Hospital of Sichuan University. Started Sep 2025; status: recruiting.
02
Drugs
sirolimus
03
Conditions
kaposiform hemangioendothelioma (KHE)
Beyond the preview
Go deeper on NCT07131644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07131644.